Windlas Biotech Ltd. Financial Overview
Windlas Biotech Ltd.'s market cap is currently ₹16.89B. The company's EPS TTM is ₹8.48; its P/E ratio is 24.87; and it has a dividend yield of 0.71%. Windlas Biotech Ltd. is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
